Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Fluzone in Healthy Infants
NCT00242424Phase 3Completed
- Sponsor
- Seattle Children's
- Start
- Sep 2005
- Primary completion
- Sep 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in influenza comparing Placebo with Fluzone (2 arms). Primary endpoint: Safety of Fluzone vaccine at 6 months. Started Sep 2005; status: completed.
02
Drugs
Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00242424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00242424.